Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Improvement in early and established arthritis with antiangiogenic therapy

Nov. 18, 1997

Potential of rhM-CIF in rheumatoid arthritis suggested by animal studies

Nov. 18, 1997

New MMP inhibitors from Pharmacia & Upjohn

Nov. 18, 1997

Celecoxib: safety and efficacy data presented at rheumatology meeting

Nov. 17, 1997

T-614, a new NSAID that appears to act as a lysosomal protease inhibitor

Nov. 14, 1997

KE-298 suppresses MMP production in RA synoviocytes

Nov. 14, 1997

Selective collagenase 3 inhibitor shows promise for osteoarthritis

Nov. 14, 1997

Preclinical antiinflammatory effects demonstrated for CT-3

Nov. 13, 1997

Minocycline associated with marked long-term efficacy in early RA

Nov. 13, 1997

Promising clinical results reported for Avakine

Nov. 13, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...